MED12 and non-small cell lung carcinoma: Interestingly, contrary to previous studies [43–49], we observed that only the ERK1/2 pathway, and not the AKT pathway, was activated in MED12 KO NSCLC cell lines exposed to the same cytokines (Fig. 3F).